Learn more about lung cancer at YouAndLungCancer.com
This animation explains how immunotherapy works for lung cancer. Immunotherapy uses medicine to stimulate the body's immune system to recognize and attack cancer cells. The immunotherapy drugs that are most often used to treat lung cancer are called "checkpoint inhibitors." On the surface of cancer cells there are proteins that “put the brakes” on the immune system. They serve as “checkpoints” that stop the immune system from launching an all-out assault on cancer. Checkpoint inhibitors work by “taking off the brakes” and giving the immune system free rein to release special cells called T cells that attack the cancer. Watch to learn about checkpoint proteins called PD-1, PD-L1, CTLA-4, considerations for combining immunotherapy with chemotherapy, as well as learn about possible side effects of immunotherapy for lung cancer.
- Understanding Immunotherapy for Lung Cancer ( Download)
- Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers ( Download)
- Understanding Immunotherapy in Lung Cancer ( Download)
- Explaining Immunotherapy, PD-L1 and PD-1 ( Download)
- Immunotherapy Treatments for Non-Small Cell Lung Cancer (NSCLC) ( Download)
- Cancer Immunotherapy Basics: Understand the science behind this cutting-edge treatment ( Download)
- Immunotherapy for Lung Cancer: Understanding the Process and Its Potential ( Download)
- Understanding Immunotherapy's Side Effects ( Download)
- Targeted Therapies: The Future of Non-small cell lung cancer (NSCLC) Treatment ( Download)
- Understanding Cancer Immunotherapy ( Download)
- Biologic basis of immunotherapy in lung cancer ( Download)
- Tumour immunology and immunotherapy ( Download)
- Understanding Immunotherapy in Cancer Treatment – University Hospitals Seidman Cancer Center ( Download)
- Understanding Immunotherapy ( Download)
- Cancer immunotherapy | The PD-L1 pathway ( Download)
